## **Core Concept**
The question tests the understanding of drug safety in patients with bronchial asthma. Certain classes of drugs can exacerbate asthma or are contraindicated due to their mechanism of action, which can lead to bronchoconstriction or inflammation.

## **Why the Correct Answer is Right**
Aspirin (option ) is not inherently contraindicated in bronchial asthma but can be problematic in patients with aspirin-exacerbated respiratory disease (AERD). However, among the given options and in a general context, is often considered safe or not universally contraindicated like non-selective beta-blockers or NSAIDs (except for those with AERD). The correct answer requires identifying a drug that does not universally worsen or is not contraindicated in asthma.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Non-selective beta-blockers (e.g., propranolol) are contraindicated in asthma because they can cause bronchoconstriction by blocking β2 receptors in the lungs, which are responsible for bronchodilation.
- **Option B:** NSAIDs (e.g., ibuprofen) can be problematic for patients with asthma, especially those with AERD, as they can trigger or worsen asthma symptoms.
- **Option D:** Atropine or anticholinergics can be used cautiously but are generally not contraindicated; however, their use might be limited by side effects. The concern with some options might relate to their potential to dry secretions.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while many drugs can be problematic for patients with asthma, the term "contraindicated" implies a strong warning against use. Drugs like **non-selective beta-blockers** are classically contraindicated. For patients with asthma, always consider the risk-benefit ratio and potential alternatives.

## **Correct Answer:** .